Mary-Catherine Stockman1, Dylan Thomas2, Jacquelyn Burke3, Caroline M Apovian2. 1. Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center, 720 Harrison Avenue, 8th Floor, Boston, MA, 02118, USA. Mary-Catherine.Stockman@bmc.org. 2. Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center, 720 Harrison Avenue, 8th Floor, Boston, MA, 02118, USA. 3. College of Health and Rehabilitation Sciences, Boston University Sargent College, 635 Commonwealth Avenue, Boston, MA, 02215, USA.
Abstract
PURPOSE OF REVIEW: We review the underlying mechanisms and potential benefits of intermittent fasting (IF) from animal models and recent clinical trials. RECENT FINDINGS: Numerous variations of IF exist, and study protocols vary greatly in their interpretations of this weight loss trend. Most human IF studies result in minimal weight loss and marginal improvements in metabolic biomarkers, though outcomes vary. Some animal models have found that IF reduces oxidative stress, improves cognition, and delays aging. Additionally, IF has anti-inflammatory effects, promotes autophagy, and benefits the gut microbiome. The benefit-to-harm ratio varies by model, IF protocol, age at initiation, and duration. We provide an integrated perspective on potential benefits of IF as well as key areas for future investigation. In clinical trials, caloric restriction and IF result in similar degrees of weight loss and improvement in insulin sensitivity. Although these data suggest that IF may be a promising weight loss method, IF trials have been of moderate sample size and limited duration. More rigorous research is needed.
PURPOSE OF REVIEW: We review the underlying mechanisms and potential benefits of intermittent fasting (IF) from animal models and recent clinical trials. RECENT FINDINGS: Numerous variations of IF exist, and study protocols vary greatly in their interpretations of this weight loss trend. Most human IF studies result in minimal weight loss and marginal improvements in metabolic biomarkers, though outcomes vary. Some animal models have found that IF reduces oxidative stress, improves cognition, and delays aging. Additionally, IF has anti-inflammatory effects, promotes autophagy, and benefits the gut microbiome. The benefit-to-harm ratio varies by model, IF protocol, age at initiation, and duration. We provide an integrated perspective on potential benefits of IF as well as key areas for future investigation. In clinical trials, caloric restriction and IF result in similar degrees of weight loss and improvement in insulin sensitivity. Although these data suggest that IF may be a promising weight loss method, IF trials have been of moderate sample size and limited duration. More rigorous research is needed.
Authors: Martin P Wegman; Michael H Guo; Douglas M Bennion; Meena N Shankar; Stephen M Chrzanowski; Leslie A Goldberg; Jinze Xu; Tiffany A Williams; Xiaomin Lu; Stephen I Hsu; Stephen D Anton; Christiaan Leeuwenburgh; Mark L Brantly Journal: Rejuvenation Res Date: 2015-04 Impact factor: 4.663
Authors: Steven Pratscher; Angela M Mickle; John G Marks; Harold Rocha; Felix Bartsch; Jeffrey Schmidt; Lazaro Tejera; Steven Garcia; Carlo Custodero; Federlin Jean; Cynthia Garvan; Alisa J Johnson; Ralisa Pop; Anthony Greene; Adam J Woods; Roland Staud; Roger B Fillingim; Andreas Keil; Kimberly T Sibille Journal: Nutrients Date: 2021-05-05 Impact factor: 5.717
Authors: Aaron Persinger; Matthew Butawan; Martina Faietti; Ashley Pryke; Kyley Rose; Marie van der Merwe; Richard J Bloomer; Melissa J Puppa Journal: Nutrients Date: 2021-05-19 Impact factor: 5.717
Authors: Przemysław Domaszewski; Mariusz Konieczny; Paweł Pakosz; Dawid Bączkowicz; Ewa Sadowska-Krępa Journal: Int J Environ Res Public Health Date: 2020-06-10 Impact factor: 3.390